Supply breakdown
Shares as of Jul 31, 2026| Category | Shares | % | Value | Status |
|---|---|---|---|---|
| Circulating | 253.46M | 100.0% | $125.90B | Estimated |
| Free float | - | - | - | Unavailable |
| Insider-held, unrestricted | - | - | - | Unavailable |
| Locked team funds | 0 | 0.0% | $0 | Unavailable |
| Other restricted | 0 | 0.0% | $0 | Unavailable |
| Total outstanding | 253.46M | 100.0% | $125.90B | Verified |
| Ownership views (overlap the categories above, never added) | ||||
| Institutional holdings (13F) | 241.44M | 95.3% | $119.93B | Estimated |
| Insider-held, all (Forms 3, 4, 5) | - | - | - | Unavailable |
Institutional and insider holdings can include both tradable and locked shares, so they are shown for reference and never added to the total. Check: circulating + locked team + other restricted = total outstanding reconciles.
Valuation
- Traditional$125.90B
- Fully diluted$126.65B
- Circulating$125.90B
- Free float-
- Locked team value$0
- Other restricted value$0
Locked and restricted shares
Not reviewed yet.
Institutional holders
| Holder | Shares | % of total |
|---|---|---|
| Capital World Investors | 26.12M | 10.30% |
| BlackRock, Inc. | 24.11M | 9.51% |
| Capital Research Global Investors | 19.49M | 7.69% |
| VANGUARD CAPITAL MANAGEMENT LLC | 16.58M | 6.54% |
| STATE STREET CORP | 11.87M | 4.68% |
| Invesco Ltd. | 8.04M | 3.17% |
| JPMORGAN CHASE & CO | 6.52M | 2.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 6.02M | 2.37% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.88M | 1.92% |
| Capital International Investors | 4.70M | 1.85% |
Insiders
Forms 3, 4 and 5Form 4 aggregation pending
Share classes
| Class | Listing | Shares outstanding | As of |
|---|---|---|---|
| Common stock | VRTX on Nasdaq | 253,460,924 | Jul 31, 2026 |
Notes and sources
- VERTEX PHARMACEUTICALS INC / MA 10-Q for period ended 2026-06-30, Cover page (0000875320-26-000259)
- SEC public float (non-affiliates): $113.40B as of Jun 30, 2025, from the 10-K cover. It is a dollar value at a past date, not circulating supply.